Status Asthmaticus Clinical Trial
Official title:
Safety and Efficacy of Early Initiation of Noninvasive Positive Pressure Ventilation in Pediatric Patients Admitted With Status Asthmaticus
Status asthmaticus is recognized as a common cause of morbidity in children in the United States. In recent years, hospitalization rates have reached an all time high. This study will evaluate the safety, tolerability and clinical benefit of adding Noninvasive Positive Pressure Ventilation (NPPV)to regular care in children with moderate to moderately severe status asthmaticus.
Status asthmaticus is defined as severe asthma that fails to respond to inhaled short acting
β agonists (SABA), oral or intravenous steroids, and oxygen, leading to hospital admission
for further management (1). In 2004, asthma exacerbations led to 3% (198,000) of all
hospitalizations and 2.5 deaths per 1 million populations in the 0-17 year age group (2).
This prospective, unblinded, randomized controlled, pilot clinical trial will compare NPPV
plus standard of care versus standard of care alone in children admitted for status
asthmaticus. NPPV refers to the delivery of pressurized gas through an external interface
such as a nasal or oronasal mask, connected to a pressure targeted ventilator. In other
words, it provides ventilator support without the use of an endotracheal tube.
This study will investigate the safety, tolerability and efficacy of early initiation of
non-invasive NPPV in pediatric patients admitted with status asthmaticus.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02872597 -
Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus
|
Phase 1 | |
| Terminated |
NCT02966184 -
Comparison of Albuterol for Status Asthmaticus
|
Phase 4 | |
| Enrolling by invitation |
NCT00750568 -
Intravenous Terbutaline in Severe Status Asthmaticus
|
N/A | |
| Completed |
NCT00124995 -
Trial of Terbutaline for the Treatment of Status Asthmaticus in Children
|
Phase 4 | |
| Recruiting |
NCT05819541 -
Treating Exacerbations of Asthma With Oral Montelukast in Children
|
Phase 2 | |
| Completed |
NCT01524198 -
The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room
|
Phase 2/Phase 3 | |
| Terminated |
NCT02780479 -
Steroids in Children Hospitalized With Asthma
|
Phase 4 | |
| Withdrawn |
NCT01403428 -
Non Invasive Positive Pressure Ventilation in Status Asthmaticus
|
Phase 2 | |
| Terminated |
NCT00683449 -
Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma
|
Phase 2 | |
| Withdrawn |
NCT03219736 -
NiPPV in the Treatment of Acute Asthma Exacerbations
|
N/A | |
| Completed |
NCT00722020 -
HFCWO in Hospitalized Asthmatic Children
|
N/A | |
| Withdrawn |
NCT03338205 -
The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus
|
Phase 3 | |
| Completed |
NCT02302261 -
Pleth Variability and Asthma Severity in Children
|
N/A | |
| Recruiting |
NCT01770899 -
Evaluation Montelukast in the Treatment of Status Asthmaticus
|
N/A | |
| Withdrawn |
NCT04656587 -
BPAP in Pediatric Asthma Pilot Study
|
N/A | |
| Completed |
NCT04929626 -
Different Doses of Nebulized Magnesium Sulphate in Status Asthmaticus
|
Phase 1 | |
| Completed |
NCT00623688 -
Effectiveness and Cost Study Comparing Two Ways to Deliver Albuterol for the Treatment of Asthma in the Hospital
|
N/A | |
| Recruiting |
NCT00494572 -
Montelukast With Status Asthmaticus, Ages 6-18
|
Phase 2/Phase 3 | |
| Recruiting |
NCT00491790 -
Montelukast With Status Asthmaticus, Ages 2-5
|
Phase 2/Phase 3 | |
| Completed |
NCT00279786 -
B2-Adrenergic Receptor Polymorphisms
|